Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial

Young‐Suk Lim, Ming‐Lung Yu, Jonggi Choi, Chi-Yi Chen, Won‐Mook Choi, Wonseok Kang, Gi‐Ae Kim, Hyung Joon Kim, Yun Bin Lee, Jeong‐Hoon Lee, Neung Hwa Park, So Young Kwon, Soo Young Park, Jihoon T. Kim, Gwang Hyeon Choi, Eun Sun Jang, Chien‐Hung Chen, Yao‐Chun Hsu, Ming‐Jong Bair, Pin‐Nan Cheng, Hung‐Da Tung, Te-Sheng Chang, Gin‐Ho Lo, Kuo‐Chih Tseng, Sheng‐Shun Yang, Cheng‐Yuan Peng, Seungbong Han